Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.54B |
| 2 |
Apple
AAPL
|
+$5.8B |
| 3 |
Amazon
AMZN
|
+$3.28B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.19B |
| 5 |
Mastercard
MA
|
+$3.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$380M |
| 2 |
Twilio
TWLO
|
+$357M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$329M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$150M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.7% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Theravance Biopharma
TBPH
$873M
| $224K | ﹤0.01% |
21,978
+10,904
| +98% | +$102K |
|
|
EVBG
2352
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $224K | ﹤0.01% |
7,226
+17
| +0.2% | +$558 |
|
2353
Axsome Therapeutics
AXSM
$11.7B
| $222K | ﹤0.01% |
+4,968
| New | +$248K |
|
|
RDFN
2354
DELISTED
Redfin
RDFN
| $222K | ﹤0.01% |
37,880
-3,709,891
| -99% | -$32.9M |
|
|
BRG
2355
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $221K | ﹤0.01% |
+8,249
| New | +$217K |
|
2356
Relmada Therapeutics
RLMD
$540M
| $220K | ﹤0.01% |
+5,937
| New | +$164K |
|
2357
TriMas Corp
TRS
$1.41B
| $220K | ﹤0.01% |
8,764
+15
| +0.2% | +$413 |
|
2358
Vanda Pharmaceuticals
VNDA
$304M
| $220K | ﹤0.01% |
22,292
+11,162
| +100% | +$118K |
|
|
MODN
2359
DELISTED
MODEL N, INC.
MODN
| $220K | ﹤0.01% |
+6,430
| New | +$186K |
|
|
MNRL
2360
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $219K | ﹤0.01% |
8,896
+34
| +0.4% | +$908 |
|
|
BRSP
2361
BrightSpire Capital
BRSP
$634M
| $218K | ﹤0.01% |
34,448
+17,054
| +98% | +$141K |
|
2362
Clover Health Investments
CLOV
$2.23B
| $218K | ﹤0.01% |
127,682
+63,752
| +100% | +$167K |
|
2363
OneSpaWorld
OSW
$2.64B
| $218K | ﹤0.01% |
25,952
+12,976
| +100% | +$109K |
|
2364
Sphere Entertainment
SPHR
$5.02B
| $218K | ﹤0.01% |
4,967
+8
| +0.2% | +$449 |
|
2365
Tompkins Financial
TMP
$1.42B
| $218K | ﹤0.01% |
3,010
-14
| -0.5% | -$1.05K |
|
2366
Amphastar Pharmaceuticals
AMPH
$907M
| $217K | ﹤0.01% |
7,715
-52
| -0.7% | -$1.7K |
|
2367
QuinStreet
QNST
$927M
| $216K | ﹤0.01% |
20,580
+10,294
| +100% | +$117K |
|
2368
WisdomTree
WT
$2.79B
| $216K | ﹤0.01% |
45,824
+22,846
| +99% | +$117K |
|
2369
First Bancorp
FBNC
$2.61B
| $214K | ﹤0.01% |
5,846
+12
| +0.2% | +$441 |
|
|
HSII
2370
DELISTED
Heidrick & Struggles
HSII
| $214K | ﹤0.01% |
8,229
-164
| -2% | -$4.84K |
|
2371
Interface
TILE
$1.95B
| $214K | ﹤0.01% |
23,834
+11,937
| +100% | +$145K |
|
2372
AtaiBeckley Inc
ATAI
$2.66B
| $212K | ﹤0.01% |
63,878
+31,939
| +100% | +$131K |
|
|
AVNS
2373
DELISTED
Avanos Medical
AVNS
| $212K | ﹤0.01% |
9,736
+17
| +0.2% | +$444 |
|
|
BBBY
2374
Bed Bath & Beyond
BBBY
$479M
| $212K | ﹤0.01% |
9,556
+19
| +0.2% | +$476 |
|
2375
Enova International
ENVA
$6.09B
| $212K | ﹤0.01% |
7,235
+3
| +0% | +$101 |
|
Similar funds
Janus Henderson Group's Q3 2022 Portfolio in Review
As of Q3 2022, Janus Henderson Group held 2,740 positions worth $267B, up 84% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group deployed $142B of net new capital in Q3 2022, opening 150 new positions and adding to 2,084 existing holdings. Its largest new stake was Schwab US Large- Cap ETF: 22,942,620 shares worth $324M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Snap, an estimated $380M trimmed.
- Janus Henderson Group's largest Q3 2022 buy was Schwab US Large- Cap ETF: 22,942,620 shares worth $324M.
- Janus Henderson Group added most to Microsoft in Q3 2022, an estimated $8.54B increase.
- Janus Henderson Group's biggest Q3 2022 reduction was Snap, cutting an estimated $380M.
- Janus Henderson Group fully exited Alibaba in Q3 2022, selling an estimated $65.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $267B portfolio in Q3 2022.
- Janus Henderson Group opened 150 new positions and closed 205 in Q3 2022.
- Janus Henderson Group's portfolio value rose 84% quarter-over-quarter to $267B.
Based on Janus Henderson Group's 13F filing for Q3 2022, filed 14 Nov 2022.